EUVIMEDEUVIMED entdecken
Crossref

Statin use impairs muscle strength recovery in post‐stroke patients with sarcopenia

Ayaka Matsumoto iD, Yoshihiro Yoshimura iD, Fumihiko Nagano, Takahiro Bise, Yoshifumi Kido, Sayuri Shimazu, Ai Shiraishi iD

Geriatrics & Gerontology International · 2023

DOI: 10.1111/ggi.14646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geriatrics & Gerontology International, 2023. Verfasst von Ayaka Matsumoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The effects of statins on muscle health are not well established. Therefore, this study investigated the impact of statin use on muscle strength and mass recovery in patients with sarcopenia after stroke.

Methods

This retrospective cohort study included stroke patients with sarcopenia hospitalized between 2015 and 2021 at a post‐acute rehabilitation hospital. Sarcopenia was diagnosed using handgrip strength and skeletal muscle mass index measured using bioelectrical impedance analysis according to the 2019 criteria of the Asian Working Group for Sarcopenia. The study outcomes included handgrip strength and skeletal muscle mass index at hospital discharge. We used multivariate analyses to examine whether statin use was independently associated with the outcomes. Statistical significance was set at P < 0.05.

Results

Of the 586 patients enrolled, 241 (mean age 79.3 years, 44.4% men) presented with sarcopenia and were included in the analysis. Statin use was observed in 61 (25.3%) patients. Statin use was independently negatively associated with handgrip strength at discharge ( β = −0.095, P = 0.032), but not with skeletal muscle mass index at discharge ( β = 0.019, P = 0.692).

Conclusions

Statin use was negatively associated with muscle strength recovery, but not with muscle mass in patients with sarcopenia who underwent rehabilitation after stroke. To maximize outcomes, sufficient consideration is needed for statin use in these patients. Geriatr Gerontol Int 2023; 23: 676–683 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHydroxymethylglutaryl-CoA Reductase InhibitorsStrokeMaleHumansAgedFemaleHand StrengthRetrospective StudiesMuscle StrengthMuscle, Skeletal

Stichwörter der Autor:innen

hydroxymethylglutaryl-CoA reductase inhibitorsmuscle strengthrehabilitationsarcopeniastroke

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Center for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.

ORCID-Profile: Ayaka Matsumoto, Yoshihiro Yoshimura, Ai Shiraishi

Zitieren

APA

Matsumoto, A., Yoshimura, Y., Nagano, F., Bise, T., Kido, Y., Shimazu, S., & Shiraishi, A. (2023). Statin use impairs muscle strength recovery in post‐stroke patients with sarcopenia. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.14646

Vancouver

Matsumoto A, Yoshimura Y, Nagano F, Bise T, Kido Y, Shimazu S, et al. Statin use impairs muscle strength recovery in post‐stroke patients with sarcopenia. Geriatrics & Gerontology International. 2023. doi:10.1111/ggi.14646

BibTeX
@article{Matsumoto2023,
  author = {Matsumoto, Ayaka and Yoshimura, Yoshihiro and Nagano, Fumihiko and Bise, Takahiro and Kido, Yoshifumi and Shimazu, Sayuri and Shiraishi, Ai},
  title = {Statin use impairs muscle strength recovery in post‐stroke patients with sarcopenia},
  journal = {Geriatrics & Gerontology International},
  year = {2023},
  doi = {10.1111/ggi.14646}
}
Kostenlos starten →